GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Restart Life Sciences Corp (XCNQ:HEAL) » Definitions » Short Percentage of Float

Restart Life Sciences (XCNQ:HEAL) Short Percentage of Float


View and export this data going back to 2006. Start your Free Trial

What is Restart Life Sciences Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Restart Life Sciences's Short Percentage of Float

For the Biotechnology subindustry, Restart Life Sciences's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Restart Life Sciences's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Restart Life Sciences's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Restart Life Sciences's Short Percentage of Float falls into.


Restart Life Sciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Restart Life Sciences Corp (XCNQ:HEAL) » Definitions » Short Percentage of Float
Comparable Companies
XCNQ:CHGX XCNQ:MOOD XCNQ:WBIO TSXV:WAVE XCNQ:NSHS XCNQ:AGN XCNQ:ENBI XCNQ:NIRV XCNQ:GTTX XCNQ:MBIO VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
NMLSD:USA HN3:Germany HN3:Germany
Address
700-838 West Hastings Street, Vancouver, BC, CAN, V6C 0A6
Website
https://www.novamentis.ca
Restart Life Sciences Corp is a Canadian life sciences company dedicated to addressing today's health challenges with wellness solutions. It is focus is on creating health foods that address the needs of this community. Its Flagship developments includes Autism Spectrum, Health-Related Foods, Psilocybin Clinical Trial for Fragile X Syndrome, Orphan Drug Designation (FDA and EMA).
Executives
Derek Lloyd Harry Ivany 10% Security Holder, Director, Senior Officer
Steven Feldman Director
William Rascan Director, Senior Officer

Restart Life Sciences Headlines

No Headlines